iBio Income from Cont. Ops Quarterly
iBio Income from Cont. Ops Quarterly Chart
iBio Historical Income from Cont. Ops Quarterly DataPro Data Export
There is no data for the selected date range.
About Income from Continuing Operations
Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.
For instance, if MSFT had five billion in Income, and 2 billion in an exceptional item charge, its income would be a reported 3 billion. Because the exceptional charge is unlikely to be repeated in the next quarter, some investors prefer to see what MSFT's income was BEFORE charges.
View Income from Cont. Ops Quarterly for IBIO.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
IBIO Income from Cont. Ops Quarterly Benchmarks
|Acura Pharmaceuticals||Go Pro|
|Horizon Pharma||Go Pro|
|Sagent Pharmaceuticals||Go Pro|
IBIO Income from Cont. Ops Quarterly Rankings
3496 of 7593
263 of 650 in Healthcare
24 of 65 in Drug Manufacturers - Specialty & Generic
IBIO Income from Cont. Ops Quarterly Range, Past 5 Years
|Minimum||Go Pro||Dec 2010|
|Maximum||Go Pro||Sep 2011|
Street Insider Apr 23
PR Newswire Apr 23
Street Insider Apr 22
Benzinga Apr 22
PR Newswire Apr 22